Thyroid cancer arises from a mix of established risk factors, some you can control and many you cannot. Radiation exposure during childhood is the most firmly documented cause, but the full picture includes genetics, hormones, body weight, pre-existing thyroid disease, and possibly environmental chemicals. What makes thyroid cancer unusual among malignancies is that much of its dramatic rise in incidence over recent decades appears to reflect increased detection of small, slow-growing tumors rather than a true epidemic of aggressive disease.
Radiation Exposure Is the Strongest Known Risk Factor
The link between ionizing radiation and thyroid cancer is one of the best-established cause-and-effect relationships in cancer research. The thyroid gland sits in the front of the neck, relatively close to the skin surface, and its cells are highly sensitive to radiation damage. Two variables matter most: the dose of radiation the thyroid absorbs and the age at which you are exposed. Children are far more vulnerable than adults, and the risk decreases steadily as age at exposure increases.
The clearest evidence comes from populations exposed to radiation from nuclear events. After the 1986 Chernobyl accident, radioactive iodine (iodine-131) was released into the environment and concentrated in the thyroid glands of people who consumed contaminated milk or breathed contaminated air. A long-running Ukrainian-American study that followed more than 10,000 people who were children at the time of the accident found a persistent, dose-dependent increase in both thyroid cancer and benign thyroid tumors nearly three decades later.
External beam radiation therapy during childhood, once commonly used to treat conditions like enlarged tonsils and certain childhood cancers, also carries a well-documented risk. Pooled data from nine large cohorts confirmed that even relatively low radiation doses delivered to the thyroid in childhood produce a measurable, linear increase in thyroid cancer risk.
This vulnerability during childhood is thought to reflect the rapid cell division happening in a growing thyroid gland. When DNA damage from radiation occurs in actively dividing cells, there is a greater chance that mutations will be passed on to daughter cells rather than repaired. Adults exposed to similar doses face a much lower risk, though the risk is not zero.
Diagnostic Imaging and Everyday Radiation
The radiation discussion extends beyond nuclear accidents and cancer treatment. A systematic review and meta-analysis found that repeated dental X-rays were associated with roughly double the risk of thyroid cancer compared to no such exposure.
A broader meta-analysis looking at all types of diagnostic radiation found that overall exposure to diagnostic imaging was linked to about a 50 percent increase in thyroid cancer risk. CT scans of the head and neck, and chest X-rays, each showed statistically meaningful associations. One population-based study focused specifically on thyroid microcarcinomas (tumors 10 mm or smaller) and found particularly elevated risks with head and neck CT scans and nuclear medicine examinations.
Context matters here. The absolute risk from any single dental X-ray or CT scan is tiny. These studies are looking at cumulative, repeated exposures over years. Modern dental equipment delivers far less radiation than older machines, and most imaging facilities now use thyroid shields when scanning the head and neck. Still, the findings reinforce the principle of avoiding unnecessary imaging, particularly in children and young adults whose thyroid tissue is more radiation-sensitive.
Genetics and Inherited Syndromes
Most thyroid cancers are not hereditary, but genetics plays a clear role in certain subtypes. The starkest example is medullary thyroid cancer, which arises from a different cell type than the more common papillary and follicular forms. About a quarter of medullary thyroid cancers are hereditary, caused by inherited mutations in a gene called RET. These familial cases are part of a group of syndromes collectively known as multiple endocrine neoplasia type 2, which can also cause tumors in the adrenal glands and parathyroid glands. Between 43 and 65 percent of the sporadic (non-inherited) medullary cases also harbor a RET mutation, though in those cases the mutation arose in the tumor itself rather than being inherited.
The more common forms of thyroid cancer, papillary and follicular, can also cluster in families, though the genetics are murkier. Familial non-medullary thyroid cancer appears to involve multiple genes, each with a relatively modest effect, rather than one high-impact mutation. Having a first-degree relative with thyroid cancer roughly doubles or triples your own risk, but because the baseline risk is low, the absolute increase is small for most people.
Genetic testing for RET mutations is now standard practice when medullary thyroid cancer is diagnosed. If a mutation is found, family members can be tested, and those who carry the mutation are often offered preventive thyroid removal because the lifetime risk of developing the cancer is extremely high. For non-medullary thyroid cancer, there is no equivalent single-gene test, and the familial risk is managed through more frequent screening rather than preemptive surgery.
Why Women Are Affected More Than Men
Thyroid cancer is roughly three times more common in women than in men, a disparity that has prompted decades of research into hormonal explanations. The gap appears after puberty, peaks during the reproductive years, and narrows somewhat after menopause, which strongly implicates estrogen.
Laboratory research has confirmed that estrogen acts as a growth promoter for both normal and malignant thyroid cells. It works through estrogen receptors present on thyroid tissue, and the specific receptor subtypes expressed differ depending on the type of thyroid cancer. The pattern of the sex disparity across the lifespan, rising after puberty and declining after menopause, aligns closely with estrogen levels.
Reproductive history adds nuance. A meta-analysis of reproductive factors found that certain events associated with hormonal shifts, including having more than two pregnancies, experiencing miscarriage, and undergoing artificial menopause, were each linked to moderately higher thyroid cancer risk. Prolonged use of oral contraceptives, interestingly, appeared to be protective, reducing risk by about 15 to 22 percent. However, a large analysis within the Nurses’ Health Study II found no significant link between parity, breastfeeding duration, age at first period, or menopausal status and thyroid cancer risk, highlighting that these associations remain inconsistent across studies.
One population-based study found that the risk of differentiated thyroid cancer increased meaningfully starting at four or more deliveries, with the highest risk among women who had six or more. That study noted the effect was largely driven by a subgroup of Arab women with very high parity rates, which suggests that the relationship between pregnancy count and thyroid cancer may depend on the population studied.
The honest read of this evidence is that estrogen likely contributes to the sex difference in thyroid cancer rates, but it is probably not the whole explanation. Detection bias may also play a role: women interact with the healthcare system more frequently during their reproductive years, creating more opportunities for incidental thyroid findings.
Obesity and Metabolic Disease
Carrying excess body weight is consistently linked to higher thyroid cancer risk. A 2024 meta-analysis of cohort studies found that obesity was associated with about a one-third increase in risk, and that association held across men and women, across different continents, and regardless of whether the study was prospective or retrospective. An earlier meta-analysis of 21 observational studies reached almost the identical estimate.
The mechanism likely involves chronic low-grade inflammation and hormonal changes that accompany obesity. Adipose tissue produces estrogen through a process called aromatization, which could amplify the estrogen-driven growth signals described earlier. Excess body fat also promotes insulin resistance, which leads to higher circulating levels of insulin and insulin-like growth factor-1. Both of these molecules stimulate cell growth and division, including in thyroid tissue. Research on the connection between type 2 diabetes and thyroid cancer has pointed to this insulin-driven pathway as a plausible link, with elevated insulin-like growth factor-1 promoting the proliferation of thyroid cells and activating growth-signaling pathways that are overexpressed in thyroid tumors.
The Role of Pre-Existing Thyroid Conditions
If you already have a thyroid condition, the question of cancer risk understandably looms large. Two findings stand out in the research: TSH levels within thyroid nodules, and the relationship between Hashimoto’s thyroiditis and thyroid cancer.
Thyroid-stimulating hormone (TSH) is the signal your pituitary gland sends to tell the thyroid to work harder. Several studies have found that even among people with normal thyroid function, those whose TSH levels sit at the higher end of the normal range are more likely to have malignant nodules. One prospective study found that thyroid cancer patients had notably higher median TSH levels than patients with benign nodules, and that having a TSH level above roughly 2.3 was associated with about a threefold increase in the likelihood that a nodule was cancerous. Another study set the cutoff slightly higher and found a similar pattern. This does not mean high-normal TSH causes cancer, but it does appear to be a useful marker that helps doctors assess which nodules deserve closer attention.
Hashimoto’s thyroiditis, the most common autoimmune thyroid condition, has a complicated relationship with thyroid cancer. A nationwide cohort study found that people with Hashimoto’s had nearly twelve times the rate of thyroid cancer compared to the general population, with the risk especially elevated in the first three years after diagnosis. The association is strongest with papillary thyroid cancer, the most common and generally least aggressive subtype. Studies of patients undergoing thyroid surgery for Hashimoto’s have consistently found higher rates of papillary cancer, though reassuringly, those cancers tend to have a more favorable profile and better prognosis. On the flip side, Hashimoto’s thyroiditis is also linked to primary thyroid lymphoma, a rare but distinct malignancy that appears to be driven by chronic immune stimulation of the gland.
Sorting out cause and effect here is tricky. Some of the elevated risk may reflect surveillance bias: people with Hashimoto’s undergo more thyroid imaging, which increases the chances of finding small cancers that might never have caused symptoms. Whether the autoimmune inflammation itself promotes cancer development or simply makes it more likely to be discovered remains an active debate.
Iodine, Nitrates, and What You Eat
Iodine is the raw material the thyroid uses to make its hormones, and the amount of iodine in your diet can influence which types of thyroid cancer are more common in a population. A comprehensive review of animal and human studies concluded that iodine deficiency is a risk factor for follicular thyroid cancer and possibly for anaplastic thyroid cancer, which is the rarest and most aggressive form. The mechanism involves chronic overstimulation of the thyroid by TSH when iodine is scarce, pushing thyroid cells into a state of constant growth. When countries have introduced iodine supplementation programs (typically through iodized salt), the rates of follicular and anaplastic cancers have tended to drop. However, papillary thyroid cancer rates have not shown the same pattern, and one review in the Lancet noted that overall thyroid cancer risk across a population does not appear to change much with variations in iodine intake, though the mix of subtypes may shift toward less dangerous forms.
Nitrate and nitrite, compounds found in processed meats, some vegetables, and drinking water, have also attracted attention. Nitrate can be converted in the body to nitrite, which can interfere with iodine uptake by the thyroid. A systematic review found a significant association between higher nitrite exposure and thyroid cancer risk across cohort studies. A large study using data from a major U.S. diet and health cohort found that men with the highest nitrate intake had more than double the risk of thyroid cancer compared to men with the lowest intake, though no similar trend appeared in women. These findings are suggestive but not yet conclusive, and the inconsistency between sexes makes it difficult to draw firm dietary recommendations beyond the already-standard advice to limit processed meats.
Environmental Chemicals and Geography
A growing body of research is examining whether environmental pollutants play a role in thyroid cancer, though this area is much less settled than the radiation or genetics evidence. One case-control study measured flame retardant chemicals in household dust and found that people with higher concentrations of certain compounds, particularly decabromodiphenyl ether (a common flame retardant used in electronics and furniture), were more than twice as likely to have papillary thyroid cancer. The associations varied with tumor aggressiveness and the presence of specific mutations, which suggests these chemicals may influence cancer biology in complex ways rather than acting as simple on-off switches.
Geography offers another clue. Thyroid cancer rates are significantly higher in volcanic regions, where soil and water contain elevated levels of heavy metals from non-human sources. Researchers studying populations near active volcanoes have documented higher concentrations of elements like cadmium, mercury, and vanadium in the local environment, and the data are consistent with a cause-and-effect relationship between these metal exposures and increased thyroid cancer incidence.
The Smoking Paradox
One of the more counterintuitive findings in thyroid cancer research is that smoking appears to be associated with a lower risk. A pooled analysis of five large U.S. prospective studies found that current smokers had about a 32 percent lower risk of thyroid cancer than people who had never smoked. A Korean cohort study of 10 million people found a similar reduction, around 26 percent, among current smokers. A meta-analysis confirmed the pattern, estimating roughly a 20 percent reduction in risk for smokers, with the protective effect observed in both men and women and most pronounced for differentiated thyroid cancers.
This does not mean smoking protects the thyroid in any meaningful health sense. The leading explanation is that smoking lowers TSH levels, which in turn reduces the growth-promoting stimulation the thyroid receives. Lower TSH means less thyroid cell proliferation, which may translate to fewer opportunities for cancerous transformation. The effect may also partly reflect reduced detection: smokers tend to have fewer healthcare visits and less thyroid imaging. Regardless, the massive burden of disease smoking causes through lung cancer, heart disease, and stroke makes this association a scientific curiosity rather than a reason to reach for a cigarette.
Overdiagnosis and the Rise in Thyroid Cancer Rates
Thyroid cancer incidence has risen sharply in most countries over the past several decades, and it would be irresponsible to discuss thyroid cancer causes without addressing this trend. Much of the increase is attributed to overdiagnosis of small, indolent papillary thyroid cancers that would never have caused symptoms or threatened life. The widespread and sometimes unnecessary use of ultrasound and other neck imaging has turned up vast numbers of these tiny tumors.
The clearest example comes from South Korea, where thyroid cancer screening was offered as an add-on to national cancer screening programs starting in the late 1990s. Thyroid cancer diagnoses skyrocketed, eventually becoming the most commonly diagnosed cancer in the country, but the death rate barely budged. This pattern, rising incidence with stable mortality, is the hallmark of overdiagnosis. Similar trends, though less extreme, have played out across high-income countries with widespread ultrasound access.
This does not mean thyroid cancer is never dangerous. Anaplastic thyroid cancer is one of the most lethal cancers in all of oncology, and advanced papillary or follicular cancers that have spread beyond the thyroid can be life-threatening. But the majority of thyroid cancers found today are small papillary tumors with excellent prognoses, and for many of these, active surveillance (watching with periodic ultrasound) is increasingly recommended over immediate surgery. Understanding which risk factors lead to genuinely aggressive disease versus incidentally discovered slow-growing tumors remains an important frontier in thyroid cancer research.
When Thyroid Cancer Looks Different in Other Species
Comparative research across species can reveal which aspects of thyroid cancer biology are universal and which are unique to humans. A recent genomic study comparing canine and human thyroid carcinomas found striking differences in the underlying mutations. While human thyroid cancers frequently carry known driver mutations in genes like BRAF and RAS, the canine tumors lacked these recurrently mutated driver genes altogether. Instead, roughly 60 percent of the dog tumors had mutations in DNA repair pathway genes involved in fixing errors during cell replication. This suggests that in dogs, thyroid cancer may arise more from a general breakdown in the cell’s ability to correct DNA mistakes than from the activation of specific cancer-driving genes, a fundamentally different molecular route to the same organ’s disease. These findings are a reminder that the causes of thyroid cancer, even within a single gland, can vary enormously depending on the biological context.